Joseph Rodd of AVI Clinical Research seeks participants for a new investigational drug research study now underway in the Agoura Hills.

The goal of this study is to evaluate the safety and effectiveness of an investigational drug in improving cognitive functioning for people with schizophrenia, using a new evaluation tool called MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia).

Participants are not required to change their alreadystable medication regimen. Rather, the new investigational medication is added to their currently established treatment.

Candidates for this study must be 18 to 65 years old, diagnosed with schizophrenia at or before age 35 and currently taking one of five medications for schizophrenia, which include olanzapine, risperidone/paliperidone, quetiapine or aripiprazole. Participants must also be considered outpatient and living in the community.

Qualified study participants will receive all investigational medication and studyrelated care at no cost and may also receive compensation for travel.

Anyone who suffers from schizophrenia or who knows someone diagnosed with schizophrenia may call (888) 988-6736 or visit www.cognitivestudy.com for additional information.